QT
KYNB

Quantamental Technologies’s Kyntra Bio KYNB Stock Holding History

Quantamental Technologies’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-511
Closed -$135K – 555
2022
Q2 		$135K Buy
+511
New +$131K 0.06% 373
2021
Q3 		– Sell
-417
Closed -$277K – 323
2021
Q2 		$277K Buy
+417
New +$240K 0.25% 165
2020
Q4 		– Sell
-216
Closed -$222K – 161
2020
Q3 		$222K Buy
+216
New +$232K 0.16% 213
2019
Q2 		– Sell
-2
Closed -$2K – 1583
2019
Q1 		$2K Buy
+2
New +$2.71K ﹤0.01% 1379

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Quantamental Technologies's KYNB Position: Q3 2022 in Review

Quantamental Technologies sold out of Kyntra Bio (KYNB) in Q3 2022, closing a stake of 511 shares — an estimated $135K sold.

Quantamental Technologies first reported a position in KYNB in Q1 2019 and held it in 4 quarters. The position peaked at $277K in Q2 2021. 152 funds tracked by Wall St. Rank hold KYNB as of Q3 2022.

  • Quantamental Technologies reported no remaining Kyntra Bio position as of Q3 2022 after selling out during the quarter.
  • Quantamental Technologies sold 511 Kyntra Bio shares in Q3 2022, an estimated $135K.
  • Quantamental Technologies first reported a position in Kyntra Bio in Q1 2019 and held it in 4 quarters.
  • Quantamental Technologies's Kyntra Bio position peaked at $277K in Q2 2021.
  • 152 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2022.

Based on Quantamental Technologies's 13F filing for Q3 2022, filed 14 Nov 2022.